SOLX Gold Shunt Gets Approval in Canada for Surgical Treatment of Glaucoma

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

SOLX Gold Shunt Cleared in Canada for Surgical Treatment of Glaucoma

Posted By Dr. Dominique Walton Brooks On August 12, 2009 @ 10:29 am In Glaucoma,Industry News,New Technologies,Optic Nerve | Comments Disabled

SOLX has announced that the company has received clearance from Health Canada for the use of the gold shunt in the surgical treatment of glaucoma.

In a prospective, open label study with 12 months of follow-up using SOLX’s GMS+ Gold Shunt, IOP was reduced 45.6% from the Best Medicated Baseline in patients that had failed maximum medical therapy and at least one prior surgical intervention.

The SOLX Gold Shunt is biocompatible, 99.95% pure gold and provides a pathway for the flow of aqueous humor from the anterior chamber of the eye to the suprachoroidal space. This shunt reduces IOP without the formation of a bleb.

Read ^[1] the release.

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/001950-solx-gold-shunt-cleared-in-canada-for-surgical-treatment-of-glaucoma/

URLs in this post:

[1] Read: http://www.solx.com/news/7_7_09_Canadian_Gold_Shunt_Approval.pdf

Click here to print.